Product Information
RISPERDAL CONSTA 25 MG VIAL is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $637.1656 per EA under NDC 50458030611. Its NADAC has been published 657 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the risperidone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Manufacturer
Janssen Pharmaceuticals Inc.NDC
50458030611
Classification
Brand
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
New Drug (NDA)
FDA Application
NDA021346On Market Since
10/29/2003
Price Statistics
The NADAC for RISPERDAL CONSTA 25 MG VIAL has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 122.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $637.1656 per EA |
|---|---|
| All-time high | $639.8029 (May 13, 2026) |
| All-time low | $286.3210 (Nov 28, 2013) |
| 52-week high | $639.8029 |
| 52-week low | $618.5111 |
| Median price | $486.5541 |
| Average price | $474.3741 |
| Largest weekly change | +6.9% (Jan 16, 2019) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 50% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RISPERDAL CONSTA 25 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for RISPERDAL CONSTA 25 MG VIAL, manufactured by Janssen Pharmaceuticals Inc., is $637.1656 per EA (NDC 50458030611), effective Jun 24, 2026.
How has the price of RISPERDAL CONSTA 25 MG VIAL changed over time?
Over the history we have for it, the NADAC for RISPERDAL CONSTA 25 MG VIAL has risen 122.5%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RISPERDAL CONSTA 25 MG VIAL?
Since Nov 28, 2013, the NADAC for RISPERDAL CONSTA 25 MG VIAL has ranged from a low of $286.3210 (Nov 28, 2013) to a high of $639.8029 (May 13, 2026), with a median of $486.5541 per EA.
Are there cheaper alternatives to RISPERDAL CONSTA 25 MG VIAL?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, RISPERDAL CONSTA 12.5 MG VIAL, is $318.0511 per EA — about 50% below RISPERDAL CONSTA 25 MG VIAL.
Who manufactures RISPERDAL CONSTA 25 MG VIAL?
RISPERDAL CONSTA 25 MG VIAL (NDC 50458030611) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification